Literature DB >> 3997072

Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum.

C M Chu, P Karayiannis, M J Fowler, J Monjardino, Y F Liaw, H C Thomas.   

Abstract

Hepatitis B virus DNA (HBV DNA) in serum was measured by a Spot hybridization technique in a consecutive series of 79 cases with chronic HBV infection from Taiwan. HBV DNA was found in 96.3% (52/54) of HBeAg-positive, 66% (2/3) with neither HBeAg or anti-HBe and in 63.6% (14/22) of anti-HBe positive patients. The levels of HBV DNA in the HBe-Ag-positive patients were significantly higher than in the anti-HBe positive patients (median, 944 vs. 58 pg per ml, p less than 0.001). The mean ages increased from 28.7 years for the cases with high levels of HBV DNA, to 34.7 years for those with low levels (p less than 0.01) and to 41.0 years in those without HBV DNA in serum (p less than 0.05 when compared with those with low level of HBV DNA). Ninety per cent of patients (27/30) with high levels of HBV DNA showed only minor hepatic inflammatory activity, as did 91% (10/11) of those without HBV DNA. In contrast, histologic signs of chronic active hepatitis or chronic lobular hepatitis were demonstrated in 76% of cases (29/38) with low levels of HBV DNA. These data are consistent with the hypothesis that liver damage occurs during the period of clearance of hepatocytes supporting HBV replication, and are inconsistent with the view that HBV may be directly cytopathic. Thus, the natural history of chronic HBV infection may be divided into three phases.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3997072     DOI: 10.1002/hep.1840050315

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  53 in total

1.  Effects of interferon-alpha therapy on serum and liver HBV DNA in patients with chronic hepatitis B.

Authors:  S V Feinman; B Berris; R Sooknanan; B Fernandes; S Bojarski
Journal:  Dig Dis Sci       Date:  1992-10       Impact factor: 3.199

2.  Investigation of HBV infection status in anti-HBe Chinese patients with chronic hepatitis by in situ hybridization assay.

Authors:  Y Y Zhang; Y K Wang; L J Hao; Y C Zhu
Journal:  J Tongji Med Univ       Date:  1989

3.  High level of hepatitis B virus DNA after HBeAg-to-anti-HBe seroconversion is related to coexistence of mutations in its precore and basal core promoter.

Authors:  Xiao-Mou Peng; Gui-Mei Huang; Jian-Guo Li; Yang-Su Huang; Yong-Yu Mei; Zhi-Liang Gao
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

4.  Comparison of real-time PCR assays for monitoring serum hepatitis B virus DNA levels during antiviral therapy.

Authors:  Chee-Kin Hui; Scott Bowden; Hai-Ying Zhang; Anita Wong; Sharon Lewin; Frank Rousseau; Herve Mommeja-Marin; Nikki P Lee; John M Luk; Stephen Locarnini; Nancy Leung; Nikolai V Naoumov; George K K Lau
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

5.  Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion.

Authors:  S L Tsai; P J Chen; M Y Lai; P M Yang; J L Sung; J H Huang; L H Hwang; T H Chang; D S Chen
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

6.  Viral superinfection in previously unrecognized chronic carriers of hepatitis B virus with superimposed acute fulminant versus nonfulminant hepatitis.

Authors:  C M Chu; C T Yeh; Y F Liaw
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

7.  Precore mutant of hepatitis B virus prevails in acute and chronic infections in an area in which hepatitis B is endemic.

Authors:  C M Chu; C T Yeh; C T Chiu; I S Sheen; Y F Liaw
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

8.  Immune tolerant HBV and HCC: time to revise our tolerance levels for therapy?

Authors:  Kali Zhou; Norah Terrault
Journal:  AME Med J       Date:  2018-02-10

9.  Hepatitis B in childhood: An update for the paediatrician.

Authors:  L T Yeung; E A Roberts
Journal:  Paediatr Child Health       Date:  2001-11       Impact factor: 2.253

10.  Hepatitis B virus replication in patients with chronic liver diseases.

Authors:  B M Gandhi; M Irshad; S K Acharya; Y K Joshi; B N Tandon
Journal:  Gastroenterol Jpn       Date:  1990-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.